{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:39:18Z","timestamp":1792712358920,"version":"4.5.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Various pathological changes lead to the development of heart failure (HF). HDL is dysfunctional in both acute coronary syndrome, as measured by the HDL inflammatory index (HII) assay, and stable coronary disease, as measured by cholesterol efflux capacity. We therefore hypothesized that these functions of HDL are also impaired in subjects with ischaemic cardiomyopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A case\u2013control study was performed on subjects in the University of Pennsylvania Catheterization Study (PennCath) cohort of patients with angina. Cases had EF &amp;lt;50% and angiographic CAD (\u226570% stenosis of any vessel; n = 23); controls included those with EF \u226555% and no CAD (n = 46). Serum from subjects was apolipoprotein-B depleted to isolate an HDL fraction. To measure HDL anti-oxidative capacity, the HDL fraction was incubated with LDL and a reporter lipid that fluoresces when oxidized. To measure cholesterol efflux capacity, the HDL fraction was also incubated with macrophages and tritium-labelled cholesterol. Mean HII was higher and efflux capacity lower in subjects with ischaemic cardiomyopathy (HII 0.26 vs. \u20130.028; efflux 0.80 vs. 0.92; P &amp;lt; 0.05). In a multivariable logistic regression model, both high HII and low efflux capacity were significant risk factors for HF [HII odds ratio (OR) 2.8, 95% confidence interval (CI) 2.0\u20133.9, P = 0.002; efflux OR 2.1, 95% CI 1.5\u20133.0, P = 0.03]. These effects persisted after adjustment for covariates and traditional risk factors for HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Subjects with reduced EF from ischaemia have lower HDL concentration and also impaired HDL function. HDL is a versatile lipoprotein particle with various anti-inflammatory and vasoprotective functions, whose impairment may contribute to ischaemic heart failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hft084","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T23:55:11Z","timestamp":1369439711000},"page":"1215-1219","source":"Crossref","is-referenced-by-count":55,"title":["Anti-Oxidative and Cholesterol Efflux Capacities of High-Density Lipoprotein are Reduced in Ischaemic Cardiomyopathy"],"prefix":"10.1093","volume":"15","author":[{"given":"Parin J.","family":"Patel","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Wilensky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"2026011921161213600_ejhfhft084-bib-0001","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.atherosclerosis.2009.01.023","article-title":"Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)","volume":"205","author":"Holme","year":"2009","journal-title":"Atherosclerosis"},{"key":"2026011921161213600_ejhfhft084-bib-0002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9149(02)02438-4","article-title":"Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol&gt; or=125 mg\/dl treated with statins versus no lipid-lowering drug","volume":"90","author":"Aronow","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026011921161213600_ejhfhft084-bib-0003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S0100-879X2009000500004","article-title":"Association of HDL cholesterol and triglycerides with mortality in patients with heart failure","volume":"42","author":"Freitas","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"2026011921161213600_ejhfhft084-bib-0004","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.healun.2009.04.026","article-title":"High-density lipoprotein cholesterol levels and prognosis in advanced heart failure","volume":"28","author":"Mehra","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2026011921161213600_ejhfhft084-bib-0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/ehi195","article-title":"Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy","volume":"27","author":"Christ","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011921161213600_ejhfhft084-bib-0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-5273(00)00224-2","article-title":"Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure","volume":"76","author":"Rauchhaus","year":"2000","journal-title":"Int J Cardiol"},{"key":"2026011921161213600_ejhfhft084-bib-0007","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"2026011921161213600_ejhfhft084-bib-0008","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/hrt.66.5.356","article-title":"Increased concentrations of tumour necrosis factor in \u2018cachectic\u2019 patients with severe chronic heart failure","volume":"66","author":"McMurray","year":"1991","journal-title":"Br Heart J"},{"key":"2026011921161213600_ejhfhft084-bib-0009","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0002-9149(97)00159-8","article-title":"Elevated soluble CD14 receptors and altered cytokines in chronic heart failure","volume":"79","author":"Anker","year":"1997","journal-title":"Am J Cardiol"},{"key":"2026011921161213600_ejhfhft084-bib-0010","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebauer","year":"1999","journal-title":"Lancet"},{"key":"2026011921161213600_ejhfhft084-bib-0011","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.110.958348","article-title":"Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure","volume":"4","author":"Tang","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026011921161213600_ejhfhft084-bib-0012","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"2026011921161213600_ejhfhft084-bib-0013","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000056523.08033.9F","article-title":"Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis","volume":"107","author":"Mertens","year":"2003","journal-title":"Circulation"},{"key":"2026011921161213600_ejhfhft084-bib-0014","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jacc.2011.08.030","article-title":"The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease","volume":"58","author":"Patel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011921161213600_ejhfhft084-bib-0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011921161213600_ejhfhft084-bib-0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026011921161213600_ejhfhft084-bib-0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9150(00)00524-4","article-title":"Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36","volume":"155","author":"Guy","year":"2001","journal-title":"Atherosclerosis"},{"key":"2026011921161213600_ejhfhft084-bib-0018","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejheart.2004.09.013","article-title":"Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins","volume":"7","author":"Sharma","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026011921161213600_ejhfhft084-bib-0019","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"2026011921161213600_ejhfhft084-bib-0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/eurjhf\/hfs029","article-title":"The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction","volume":"14","author":"O\u2019Connor","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011921161213600_ejhfhft084-bib-0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurjhf\/hfs128","article-title":"Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial","volume":"15","author":"Dobre","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011921161213600_ejhfhft084-bib-0022","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1536\/ihj.46.619","article-title":"The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease","volume":"46","author":"Sakatani","year":"2005","journal-title":"Int Heart J"},{"key":"2026011921161213600_ejhfhft084-bib-0023","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.109.830984","article-title":"Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study","volume":"120","author":"Velagaleti","year":"2009","journal-title":"Circulation"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhft084","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhft084","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1093\/eurjhf\/hft084","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1093\/eurjhf\/hft084","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/15\/11\/1215\/66443755\/eurjhf_15_11_1215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/15\/11\/1215\/66443755\/eurjhf_15_11_1215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:19:59Z","timestamp":1768875599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/15\/11\/1215\/8428778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,1,27]]},"published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hft084","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,11,1]]}}}